Pramlintide0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Pramlintide — research data
Regulatory statusFDA-approved (Symlin)
NCAA D1Not listed
Overview
About Pramlintide
Mechanism of action
Amylin analog; slows gastric emptying, reduces glucagon, increases satiety
Safety profile
Nausea, hypoglycemia when combined with insulin · Approved for diabetes; hypoglycemia risk (black box); nausea; requires careful dosing but manageable
Related pages